RMT

DRUG2 trials

Sponsors

Swiss Federal Institute of Technology, University of Minnesota

Conditions

ColitisImmune-related ColitisPre-Hypertension

Phase 2

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

RecruitingNCT05726396

University of MinnesotaColitis, Immune-related Colitis

Start: 2025-09-23End: 2027-02-01Target: 20Updated: 2026-06-10

Unknown Phase

Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects?

CompletedNCT03313284

Swiss Federal Institute of TechnologyPre-Hypertension

Start: 2017-09-29End: 2018-07-04Updated: 2018-08-15